Allergan Fights Preventable Blindness

After unveiling “See America,” this week, Allergen has spoken out about its commitment to fighting preventable blindness in America. The company will be partnering with Prevent Blindness, a health organization dedicated to promoting eye-health information. The two...

Roche to Expand Diabetes Sector

Following reports of Johnson & Johnson selling their diabetes division, Roche has announced plans to expand and innovate their diabetes business. This innovation comes with plans to partner with smaller companies to offer more device options. Roland Digglemann,...

Trump Confirms Medicare Drug Price Negotiations

After meeting with drug makers last week, President Trump has returned to his former claim of Medicare drug negotiations. In a Tuesday morning press brief, Whitehouse Spokesman, Sean Spicer, claimed that, yes, Trump is a proponent of Medicare negotiations. This claim...

Tarveda Raises Phase 2 Funding of Pentarin

Tarveda Therapeutics has gained $30 million in funding for Pentarin second phase clinical trials through new investor, Versant Ventures. The funding will enable the pharmaceutical company to continue developing the newest cancer treatment which combines tumor...

David Mills – Dallen Medical

8th Annual Life Science Chief Executive Officer Forum: Speaker Interview David Mills President & CEO Dallen Medical David Mills is the President & CEO of Dallen Medical Inc., a venture backed orthopedic company. Mr. Mills has approximately 25 years in the...